These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10092926)

  • 1. Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer.
    O'Donnell CJ
    Med J Aust; 1999 Mar; 170(5):236-7. PubMed ID: 10092926
    [No Abstract]   [Full Text] [Related]  

  • 2. Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer.
    Thomas DM; Mitchell PL; Berlangieri SU; Tochon-Danguy H; Knight S; Clarke CP; Scott AM
    Med J Aust; 1998 Aug; 169(4):227. PubMed ID: 9734584
    [No Abstract]   [Full Text] [Related]  

  • 3. Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma.
    Cerfolio RJ; Ojha B; Mukherjee S; Pask AH; Bass CS; Katholi CR
    J Thorac Cardiovasc Surg; 2003 Apr; 125(4):938-44. PubMed ID: 12698159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there any role for positron emission tomography-computed tomography after induction therapy for locally advanced non-small cell lung cancer?
    Crabtree TD; Sharma A
    J Thorac Cardiovasc Surg; 2016 Apr; 151(4):911-2. PubMed ID: 26478234
    [No Abstract]   [Full Text] [Related]  

  • 5. Is there a role for postinduction positron emission tomography and computed tomography with fludeoxyglucose F 18? A call for standardization.
    Nason KS
    J Thorac Cardiovasc Surg; 2016 Apr; 151(4):980-1. PubMed ID: 26872447
    [No Abstract]   [Full Text] [Related]  

  • 6. False-positive findings on [18F]FDG-PET caused by non-neoplastic cellular elements after neoadjuvant chemoradiotherapy for non-small cell lung cancer.
    Ohtsuka T; Nomori H; Watanabe K; Naruke T; Orikasa H; Yamazaki K; Suemasu K; Uno K
    Jpn J Clin Oncol; 2005 May; 35(5):271-3. PubMed ID: 15883125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of combined interpretation of computed tomography response and positron emission tomography response for prediction of prognosis after neoadjuvant chemotherapy in non-small cell lung cancer.
    Lee HY; Lee HJ; Kim YT; Kang CH; Jang BG; Chung DH; Goo JM; Park CM; Lee CH; Kang KW
    J Thorac Oncol; 2010 Apr; 5(4):497-503. PubMed ID: 20195167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome.
    Romine PE; Martins RG; Eaton KD; Wood DE; Behnia F; Goulart BHL; Mulligan MS; Wallace SG; Kell E; Bauman JE; Patel SA; Vesselle HJ
    BMC Cancer; 2019 Jan; 19(1):70. PubMed ID: 30642285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer.
    Port JL; Kent MS; Korst RJ; Keresztes R; Levin MA; Altorki NK
    Ann Thorac Surg; 2004 Jan; 77(1):254-9; discussion 259. PubMed ID: 14726072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update: NCCN non-small cell lung cancer clinical practice guidelines.
    Ettinger DS; Kris MG
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-9-13. PubMed ID: 23570092
    [No Abstract]   [Full Text] [Related]  

  • 11. Discussion.
    J Thorac Cardiovasc Surg; 2016 Apr; 151(4):978-9. PubMed ID: 26614414
    [No Abstract]   [Full Text] [Related]  

  • 12. Computed tomography response, but not positron emission tomography scan response, predicts survival after neoadjuvant chemotherapy for resectable non-small-cell lung cancer.
    Tanvetyanon T; Eikman EA; Sommers E; Robinson L; Boulware D; Bepler G
    J Clin Oncol; 2008 Oct; 26(28):4610-6. PubMed ID: 18824709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Accuracy of multislice CT in restaging patients with non-small cell lung carcinoma after neoadjuvant chemotherapy using a multiparametric approach].
    Mazzei MA; Guerrini S; Genovese EA; Voltolini L; Mazzei FG; Volterrani L; Macarini L
    Recenti Prog Med; 2012 Nov; 103(11):465-70. PubMed ID: 23096733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use.
    Weber WA; Petersen V; Schmidt B; Tyndale-Hines L; Link T; Peschel C; Schwaiger M
    J Clin Oncol; 2003 Jul; 21(14):2651-7. PubMed ID: 12860940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of posttreatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy: a brief review.
    Kased N; Erasmus JJ; Komaki R; Cox JD
    J Thorac Oncol; 2008 May; 3(5):534-8. PubMed ID: 18449010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive Neoadjuvant Chemotherapy Guided by (18)F-FDG PET in Resectable Non-Small Cell Lung Cancers: The NEOSCAN Trial.
    Chaft JE; Dunphy M; Naidoo J; Travis WD; Hellmann M; Woo K; Downey R; Rusch V; Ginsberg MS; Azzoli CG; Kris MG
    J Thorac Oncol; 2016 Apr; 11(4):537-44. PubMed ID: 26724474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete Pathologic Response When Adding Pembrolizumab to Neoadjuvant Chemotherapy in Stage IIIA Non-Small-Cell Lung Cancer.
    Hill A; Gong J; Wilczynski S; Mirza R; Erhunmwunsee L; Salgia R
    J Oncol Pract; 2018 Sep; 14(9):569-571. PubMed ID: 30044685
    [No Abstract]   [Full Text] [Related]  

  • 18. Is ¹⁸F-fluorodeoxyglucose positron emission tomography-based metabolic response superior to Response Evaluation Criteria In Solid Tumors-based response after two cycles of platinum-based chemotherapy in predicting clinical outcome of untreated patients with advanced non-small cell lung cancer?
    Yang JJ; Wang SX; Zhong WZ; Xu CR; Yan HH; Wu YL
    Nucl Med Commun; 2011 Dec; 32(12):1113-20. PubMed ID: 21934546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does FDG PET/CT have a role in determining adjuvant chemotherapy in surgical margin-negative stage IA non-small cell lung cancer patients?
    Park HL; Yoo IR; Boo SH; Park SY; Park JK; Sung SW; Moon SW
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):1021-1026. PubMed ID: 30756189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does computed tomography or positron emission tomography response after neoadjuvant chemotherapy for resectable non-small-cell lung cancer predict survival?
    Patz EF
    J Clin Oncol; 2008 Oct; 26(28):4542-3. PubMed ID: 18824705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.